# Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

> **NCT05482789** · PHASE4 · RECRUITING · sponsor: **Maisa N. Feghali, MD** · enrollment: 13 (estimated)

## Conditions studied

- Gestational Diabetes

## Interventions

- **DRUG:** Exenatide

## Key facts

- **NCT ID:** NCT05482789
- **Lead sponsor:** Maisa N. Feghali, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-12
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05482789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05482789, "Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05482789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*